Life Expectancy After Feeding Tube in ALS: Key Insights

Median survival after feeding tube placement in ALS is roughly six to seven months, though individual outcomes vary enormously depending on respiratory function, nutritional status, age, and the type of ALS a person has. That number comes from retrospective studies and represents a midpoint, not a ceiling. Some people live well over a year after the procedure, while others with advanced disease survive only weeks. The feeding tube itself does not cure ALS or fundamentally alter its trajectory, but it can stabilize nutrition, reduce the physical toll of struggling to swallow, and influence how much usable time someone has left.

What the Survival Numbers Actually Show

One of the most cited studies on post-feeding-tube survival tracked 98 ALS patients who received different types of enteral feeding. Median survival after a radiologically inserted gastrostomy (RIG) was about six months, while median survival after a standard percutaneous endoscopic gastrostomy (PEG) was about seven months. The difference between those two methods was not statistically meaningful. Patients who received a nasogastric tube, by contrast, survived a median of less than one month, reflecting the fact that nasogastric tubes tend to be placed as a last resort in people whose disease is already very advanced.¹

A larger prospective study of over 300 ALS patients who received gastrostomies found that all three common methods of insertion (PEG, RIG, and per-oral image-guided gastrostomy) carried similar survival profiles and complication rates.² The method of placement matters less than the condition of the patient at the time the tube goes in.

These medians describe populations, not individuals. A person in relatively good respiratory shape who gets a feeding tube proactively will have a very different outlook from someone whose breathing muscles are already failing. The most important factors that shift the timeline are respiratory status, body weight, age at symptom onset, and whether the person has bulbar-onset or spinal-onset disease.

Respiratory Function Is the Strongest Predictor

How well your lungs are working at the time of tube placement is, across nearly every study, the single biggest predictor of how long you will live afterward. A study of ALS patients who were already using non-invasive ventilation (NIV) routinely found that those who were dependent on their ventilator survived an average of about 133 days after gastrostomy, compared with roughly 250 days for those who used NIV but were not fully dependent on it. The 30-day mortality rate in the dependent group was over 21%, compared with under 3% in the non-dependent group.³

This does not mean that people with compromised breathing should automatically be refused a feeding tube. Research has shown that using NIV during the PEG procedure itself can make it safe even for patients with significant respiratory impairment. One early case series described five ALS patients with severe breathing problems who tolerated PEG placement without respiratory complications when supported by non-invasive ventilation during the procedure.⁴ A more recent review confirmed that NIV support during tube placement, combined with reduced sedation and an experienced team, improves safety and supports better outcomes.⁵

Forced vital capacity (FVC), the standard breathing test used to gauge lung function, has traditionally served as a gatekeeper for the procedure. Many clinicians have used a cutoff of 50% predicted FVC, below which the procedure was considered too risky. But some research challenges that threshold, finding that FVC at the time of PEG placement did not predict survival in one study.⁶ A separate study using a modified technique found that patients with low lung capacity could safely undergo PEG insertion with careful respiratory support, and concluded that FVC below 50% should not automatically rule out the procedure.⁷ The picture is shifting: respiratory status still matters enormously for prognosis, but a low FVC alone is no longer considered an absolute barrier to placement.

Why Earlier Placement Tends to Help

European clinical guidelines have long recommended that gastrostomy tubes be placed before respiratory insufficiency develops.⁸ The logic is straightforward: placing a tube while someone is in relatively good health makes the procedure safer, allows the body to recover more easily, and gives the person time to adapt to tube feeding before swallowing becomes a crisis.

In practice, many people with ALS delay the decision. Swallowing difficulties creep in gradually, and it is easy to adapt by changing food textures, eating more slowly, or relying on calorie-dense supplements. By the time oral intake becomes truly inadequate, respiratory function may have declined substantially, raising both the procedural risk and the likelihood of a shorter post-procedure survival. The data on 30-day mortality bears this out: people with more advanced disease at the time of placement are more likely to die within the first month.⁹

Recurrent accumulation of airway secretions is another warning sign that the window for safe placement is narrowing. That factor, along with older age at onset and low BMI at the time of gastrostomy, independently predicted worse survival in one regression analysis of NIV-using ALS patients.³

Bulbar Versus Spinal Onset

ALS that begins with bulbar symptoms (difficulty speaking and swallowing) and ALS that begins with limb weakness (spinal onset) behave differently after feeding tube placement, and not necessarily in the direction people expect. A study of 150 gastrostomy-fed ALS patients found that those with bulbar-onset disease had a roughly 55% lower risk of death compared with spinal-onset patients after PEG placement.¹⁰

This seems counterintuitive because bulbar ALS tends to be seen as more aggressive. But the explanation likely lies in the fact that people with bulbar symptoms are referred for feeding tubes earlier, specifically because swallowing trouble is the dominant problem. They tend to get the tube while their respiratory and overall functional status is still relatively preserved. Spinal-onset patients, by contrast, may not develop severe swallowing problems until later in the disease, by which point respiratory muscles have deteriorated more. The apparent survival advantage of bulbar patients after gastrostomy may really be a timing advantage.

Body Weight and Nutritional Status

Weight loss in ALS is not just a side effect of difficulty eating. It is an independent marker of worse outcomes. A population-based study found that the rate of monthly weight loss around the time of diagnosis predicted survival, regardless of what someone weighed before getting sick or how heavy they were at diagnosis.¹¹ This means that the speed at which someone is losing weight matters more than their absolute weight.

A BMI below 20 at the time of gastrostomy roughly doubled the risk of death compared with a higher BMI, in one analysis of ALS patients using NIV.³ Similarly, among patients who died within 30 days of feeding tube placement, the vast majority had already lost more than 10% of their usual body weight.¹²

The practical takeaway is that a feeding tube works best as a preventive measure against further decline, not as a rescue intervention after someone has already become severely malnourished. By the time someone is critically underweight, the disease has usually advanced to a point where the tube can do less to change the trajectory.

What Gets Fed Through the Tube Matters Too

Not all tube-fed diets are the same, and there is evidence that what goes through the tube can influence outcomes. A study comparing high-calorie complete nutrition to routine diet in gastrostomy-fed ALS patients found that the high-calorie group showed significant improvements in body weight, blood protein markers, and lymphocyte counts at six months. More strikingly, the cumulative survival rate was significantly better in the high-calorie group.¹³

ALS increases metabolic demand in ways researchers still do not fully understand. People with ALS often burn more calories at rest than healthy individuals, which means simply matching a “normal” caloric intake through a feeding tube may not be enough to prevent ongoing weight loss. High-calorie formulations appear to counteract this hypermetabolism more effectively. Patients and caregivers who assume the tube alone solves the nutrition problem may miss the importance of working with a dietitian to calibrate calorie and nutrient delivery.

The First 30 Days After Placement

The early post-procedure period carries real risk. Across the large prospective ProGas study, about 4% of patients died within 30 days of gastrostomy.² A separate review of patients at Midwest ALS clinics found a similar 30-day mortality rate of about 4.5%, with about 8% needing hospital readmission within that window.¹²

The most common major complications in that review were abscess and aspiration pneumonia, each affecting about 2% of patients. Minor complications were far more frequent: pain at the insertion site affected about 38% of patients, and tube migration occurred in roughly 13%. Pain tends to settle within the first week or two, but tube displacement can require medical attention. These complications are manageable in most cases, but they underscore why the procedure should be done at centers with experience in ALS gastrostomy rather than as a routine general surgery.

Age and Cognitive Factors

Older age at symptom onset consistently predicts shorter survival after gastrostomy. Two separate analyses found that each additional year of age at onset increased the risk of death by roughly 5 to 7%.³¹⁴ This is partly because older adults tend to have more comorbidities and less physiologic reserve, and partly because ALS itself tends to progress faster in older patients.

Cognitive changes add another layer of complexity. A subset of people with ALS develop frontotemporal features including changes in behavior, judgment, and eating habits. Research has found that these cognitive changes alter food preferences and caloric intake, sometimes increasing BMI in ways that mask the usual pattern of progressive weight loss.¹⁵ For caregivers, this can make the feeding tube decision confusing: someone who appears to be eating more may still benefit from tube placement if the eating changes are driven by cognitive decline rather than genuine appetite, or if swallowing safety is compromised despite increased intake.

The Caregiver Side of the Decision

Most conversations about feeding tubes focus on the patient, but the reality is that someone else usually manages the tube. Caregivers of ALS patients with gastrostomy tubes report significant emotional stress and unmet practical needs, including uncertainty about how to operate and maintain the tube, how to handle complications, and how to balance tube feeding with the person’s remaining ability to eat by mouth.¹⁶

Caregiver strain does not necessarily follow a predictable pattern after tube placement. One pilot study found that psychosocial dynamics within the patient-caregiver relationship may be stronger predictors of caregiver burden than the feeding tube itself, suggesting that some caregivers adapt well while others are overwhelmed regardless of the medical specifics.¹⁷ This is worth knowing for families weighing the decision: the tube can simplify mealtime and reduce the anxiety of watching someone choke, but it introduces its own set of daily tasks and worries. Asking for a hands-on training session and a clear point of contact for troubleshooting makes a real difference in how manageable the transition feels.

What the Tube Does and Does Not Change About Quality of Life

Feeding tubes improve nutrition and quality of life, according to European clinical guidelines.⁸ Patients with gastrostomy tubes consistently report benefits in terms of weight stabilization and reduced mealtime distress.¹⁸ But the tube does not slow the disease itself. Muscle wasting, respiratory decline, and loss of function continue at the same pace. What the tube does is remove one source of suffering — the exhausting, sometimes dangerous act of trying to eat when swallowing no longer works properly — and free up energy and time that would otherwise be spent on grueling meals.

Many people with ALS continue eating small amounts by mouth after tube placement, using the tube primarily to ensure adequate calorie and fluid intake. The two approaches are not mutually exclusive. Eating favorite foods for pleasure while relying on the tube for nutrition is a common and reasonable strategy, provided the person’s swallowing has been assessed and the aspiration risk is understood.

Healthcare Access and the Limits of the Data

One large retrospective study of nearly 2,000 ALS patients found that only about 10% showed evidence of enteral nutrition use, suggesting that feeding tubes remain underutilized relative to the number of patients who develop swallowing difficulty. The median time from ALS diagnosis to evidence of tube feeding was about 211 days. Patients who received tube feeding had more comorbidities overall, and many lost their insurance coverage within about five months of starting enteral nutrition, making it difficult for researchers to track long-term outcomes.¹⁹

That insurance gap is a practical problem worth knowing about. If you or a family member is considering a feeding tube, verifying that your coverage will extend through the period of tube feeding, and understanding what happens if coverage lapses, is as important as any clinical discussion. Tube feeding requires ongoing supplies, formula, and sometimes nursing support, and disruptions in coverage can create real hardship during an already difficult time.

The research itself has limits that are worth being honest about. There are no large randomized controlled trials comparing feeding tubes to no feeding tubes in ALS, and for ethical reasons, there probably never will be. Almost everything known about survival after gastrostomy comes from observational studies, which means the people who get tubes earlier tend to be healthier, making it hard to separate the benefit of the tube from the benefit of being in better shape. The Cochrane review on enteral feeding in ALS has noted this limitation repeatedly.⁹ What clinicians work with is a consistent pattern across multiple observational studies, all pointing in the same direction: maintaining nutrition through a feeding tube appears to support longer survival and better quality of life, particularly when placement happens before the person is in crisis.